
| Trademark | TAVANTA THERAPEUTICS |
| Trademark Type | Wordmark |
| Class | 42 |
| Application Number | 4816736 |
| Nature/Scope of business | Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds. |
| Status | Provisional Refusal Confirmed |
| Applicant: | Tavanta Therapeutics, Inc. |
| Applicant Address | 201 King of Prussia Road, Suite 650 Radnor PA 19087 US |
Get your trademark registered with expert guidance. Limited time offer!
File NowComprehensive analysis of your trademark search delivered to your phone
What you'll get: